These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 15668475

  • 1. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 4. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 6. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
    Eng-Wong J, Hursting SD, Venzon D, Perkins SN, Zujewski JA.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 8. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342
    [Abstract] [Full Text] [Related]

  • 9. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov 15; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 10. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 15; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May 15; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

  • 12. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ, Holly JM, Gunnell D, Tretli S.
    Cancer Epidemiol Biomarkers Prev; 2008 Aug 15; 17(8):2097-100. PubMed ID: 18708402
    [Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun 15; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May 15; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 16. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 15; 14(3):699-704. PubMed ID: 15767352
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
    Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS.
    Epidemiology; 1998 Sep 15; 9(5):570-3. PubMed ID: 9730040
    [Abstract] [Full Text] [Related]

  • 18. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul 15; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 19. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 15; 11(11):1361-8. PubMed ID: 12433712
    [Abstract] [Full Text] [Related]

  • 20. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 15; 15(6):1137-41. PubMed ID: 16775172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.